Related Experiment Video
Updated: Aug 13, 2026

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
[Nicotine Harms the Heart: No Safe Product, No Excuse for Political Inaction]
Abstract:
Nicotine is an independent and frequently underestimated cardiovascular risk factor. While prevention strategies have long focused on tobacco smoke and combustion products, current evidence clearly shows that nicotine itself is vasculotoxic, regardless of the delivery mode. Through sympathetic activation, blood pressure elevation, oxidative stress, endothelial dysfunction, and prothrombotic effects, nicotine drives the initiation and progression of cardiovascular disease. Most nicotine-associated mortality is cardiovascular and often occurs earlier than cancer outcomes. New nicotine products such as e-cigarettes, heat-not-burn devices, and oral nicotine pouches do not reduce this risk but increasingly shift exposure toward younger populations. A consistent, product-spanning early warning signal is the endothelial dysfunction, a validated predictor of future cardiovascular events, which is reversible only with complete nicotine abstinence. Unified, risk-based regulation of all nicotine-containing products is therefore a central pillar of effective cardiovascular prevention.
Insights
Nicotine is a significant cardiovascular risk factor, causing harm regardless of product type. Complete nicotine abstinence is crucial for preventing and reversing nicotine-induced endothelial dysfunction and cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Toxicology
- Public Health
Background:
- Nicotine is an underestimated cardiovascular risk factor.
- Prevention strategies have focused on tobacco smoke, but nicotine itself is vasculotoxic.
- Nicotine exposure is increasing in younger populations via new products.
Purpose of the Study:
- To highlight nicotine's independent role in cardiovascular disease.
- To emphasize the vasculotoxic effects of nicotine across all delivery modes.
- To advocate for unified regulation of nicotine products for cardiovascular prevention.
Main Methods:
- Review of current evidence on nicotine's cardiovascular effects.
- Analysis of nicotine's mechanisms of action (sympathetic activation, oxidative stress, etc.).
- Assessment of endothelial dysfunction as a biomarker.
Main Results:
- Nicotine independently drives cardiovascular disease initiation and progression.
- Nicotine-induced endothelial dysfunction is a consistent early warning signal.
- New nicotine products do not mitigate cardiovascular risk.
Conclusions:
- Nicotine is a potent cardiovascular risk factor, independent of delivery method.
- Endothelial dysfunction is a key indicator of nicotine-induced vascular damage.
- Unified, risk-based regulation of all nicotine products is essential for cardiovascular health.
More Related Videos
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Stress Prevention and Stress Management Techniques IV

